Benefits of Equine-Assisted Therapies in People with Multiple Sclerosis: A Systematic Review.
Journal
Evidence-based complementary and alternative medicine : eCAM
ISSN: 1741-427X
Titre abrégé: Evid Based Complement Alternat Med
Pays: United States
ID NLM: 101215021
Informations de publication
Date de publication:
2022
2022
Historique:
received:
18
09
2021
accepted:
04
04
2022
entrez:
9
5
2022
pubmed:
10
5
2022
medline:
10
5
2022
Statut:
epublish
Résumé
This systematic review aimed to provide an up-to-date analysis of the effects of equine-assisted therapies (EAT) in people with multiple sclerosis (PwMS). The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed to conduct this systematic review. PubMed and Web of Science databases were employed in the search, which ended in February 2022. The risk of bias analysis was performed using the Evidence Project tool. After removing duplicates, thirty-nine studies were identified. However, only ten fulfilled the inclusion criteria and were included in this systematic review. Therefore, a total of 195 PwMS, aged between 40.3 and 51.3, were included in this systematic review. EAT-based interventions had a mean length of 13.6 weeks with a session´s frequency ranging from ten to once a week. All sessions involved real horses and lasted a mean of 34.4 min. Among the included articles, four were randomized controlled trials (RCT), four did not perform randomization, and two employed a prepost design without a control group. RCTs showed positive effects on quality of life, fatigue, balance, spasticity, and gait speed. Furthermore, non-RCT showed improvements in balance, spasticity, and postural control (postural control was not assessed in RCT studies). Importantly, significant effects were only observed when the comparison group was inactive or followed usual care. Therefore, EAT is a promising and effective therapy to improve quality of life, fatigue, balance, spasticity, and gait speed in PwMS. However, since comparison groups are heterogeneous, results could vary depending on the research design. Moreover, the inclusion of noncontrolled studies (in order to have a wide perspective of the state of art) could increase the risk of bias and make the results be taken with caution.
Identifiants
pubmed: 35529929
doi: 10.1155/2022/9656503
pmc: PMC9068279
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
9656503Informations de copyright
Copyright © 2022 Ana Myriam Lavín-Pérez et al.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
PLoS Med. 2009 Jul 21;6(7):e1000100
pubmed: 19621070
Hum Mov Sci. 2015 Feb;39:121-37
pubmed: 25436916
Br J Math Stat Psychol. 2009 Feb;62(Pt 1):97-128
pubmed: 18001516
Arq Neuropsiquiatr. 2011 Oct;69(5):799-804
pubmed: 22042184
Radiol Technol. 2016 May;87(5):529-50
pubmed: 27146176
Eur J Phys Rehabil Med. 2008 Mar;44(1):99-100
pubmed: 18385635
Psychiatr Pol. 2017 Oct 29;51(5):923-935
pubmed: 29289971
Disabil Rehabil. 2018 Mar;40(5):522-526
pubmed: 27927030
Arch Phys Med Rehabil. 2009 Jul;90(7):1185-95
pubmed: 19577032
Complement Ther Med. 2021 Jan;56:102595
pubmed: 33197670
J Phys Ther Sci. 2014 Sep;26(9):1325-7
pubmed: 25276009
Qual Life Res. 1995 Jun;4(3):187-206
pubmed: 7613530
J Neurol Neurosurg Psychiatry. 2006 Jan;77(1):34-9
pubmed: 16361589
J Med Life. 2010 Oct-Dec;3(4):352-8
pubmed: 21254730
Med Clin (Barc). 2019 Jan 18;152(2):55-58
pubmed: 29680460
Arch Phys Med Rehabil. 2014 Dec;95(12):2428-34
pubmed: 25004466
Physiother Theory Pract. 2005 Jan-Mar;21(1):51-77
pubmed: 16385943
BMC Neurol. 2017 Sep 16;17(1):185
pubmed: 28915856
Physiother Theory Pract. 2015;31(8):575-81
pubmed: 26467902
Handb Clin Neurol. 2018;159:237-250
pubmed: 30482317
Medicina (Kaunas). 2020 Aug 31;56(9):
pubmed: 32878327
Heliyon. 2018 Sep 11;4(9):e00777
pubmed: 30225377
NeuroRehabilitation. 2016 Jun 30;39(2):305-17
pubmed: 27372366
Front Neurol. 2019 Aug 13;10:834
pubmed: 31456733
J Neurol Neurosurg Psychiatry. 2018 Jan;89(1):34-41
pubmed: 28768821
Panminerva Med. 2011 Jun;53(2):129-36
pubmed: 21659977
J Altern Complement Med. 2011 Mar;17(3):191-7
pubmed: 21385087
Neurology. 1983 Nov;33(11):1444-52
pubmed: 6685237
Disabil Rehabil. 2013 Jan;35(2):89-99
pubmed: 22630812
Arch Phys Med Rehabil. 2017 Feb;98(2):337-340.e2
pubmed: 27789239
Sleep. 2010 Aug;33(8):1061-7
pubmed: 20815187
Int J Environ Res Public Health. 2019 Dec 25;17(1):
pubmed: 31881693
J Neurol Phys Ther. 2007 Jun;31(2):77-84
pubmed: 17558361
Mult Scler. 2001 Apr;7(2):119-30
pubmed: 11424632
Mult Scler Relat Disord. 2020 Aug;43:102203
pubmed: 32485633
Arch Phys Med Rehabil. 2013 Sep;94(9):1800-1828.e3
pubmed: 23669008
Mult Scler Relat Disord. 2019 Oct;35:158-163
pubmed: 31400557
Mult Scler Relat Disord. 2021 Jul;52:102948
pubmed: 33940496
Nurs Open. 2019 Sep 27;7(1):58-67
pubmed: 31871691
J Autism Dev Disord. 2018 Mar;48(3):759-769
pubmed: 29196865
Eur J Phys Rehabil Med. 2015 Feb;51(1):23-30
pubmed: 24755773
J Autism Dev Disord. 2017 Oct;47(10):3220-3242
pubmed: 28733851
Curr Neurol Neurosci Rep. 2010 Sep;10(5):407-12
pubmed: 20567946
N Engl J Med. 1991 Aug 15;325(7):467-72
pubmed: 1852181
PM R. 2018 Oct;10(10):1062-1072
pubmed: 29626616
J Psychiatr Ment Health Nurs. 2021 Dec;28(6):1079-1091
pubmed: 33171006
Syst Rev. 2019 Jan 3;8(1):3
pubmed: 30606262
Vet Sci. 2017 Sep 08;4(3):
pubmed: 29056702
Comput Biol Med. 2004 Mar;34(2):113-25
pubmed: 14972631
Arch Gerontol Geriatr. 2013 May-Jun;56(3):478-81
pubmed: 23290005
G Ital Med Lav Ergon. 2011 Oct-Dec;33(4):462-7
pubmed: 22452106
Mult Scler Relat Disord. 2019 Nov;36:101386
pubmed: 31520986
Eur J Phys Rehabil Med. 2010 Sep;46(3):347-53
pubmed: 20927000
Mult Scler. 2018 Sep;24(10):1375-1382
pubmed: 28770664